Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AVGO vs GSK✓SelectedUSD · GSKAVGO vs GSK performance historyLatest closeAs of-12.19%11/20
Stock and ETF performance explorer

AVGO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,198.2%
GSK return
+97.4%
Excess return
+2,100.8%
Maximum drawdown
-48.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-12.2%-0.1%-12.1%-12.2%
7D-12.3%-5.3%-6.9%-11.1%
30D-9.9%-3.7%-6.2%-9.2%
3M-16.2%-7.3%-9.0%-14.9%
6M-26.9%-4.2%-22.6%-26.9%
YTD-11.6%+0.9%-12.4%-13.7%
1Y-11.6%+7.3%-18.9%-15.5%
3Y+215.8%+52.7%+163.1%+151.8%
5Y+484.7%+40.1%+444.6%+373.0%
All+2,198.2%+97.4%+2,100.8%+1,486.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling